Cardiovascular diseases in combination with SARS-CoV-2 viral infection: cours and forecast

• Published in: Ateroskleroz Vol. 17; no. 3; pp. 97 - 105
• Main Authors: Gushchina, O. I., Lozhkina, N. G.
• Format: Journal Article
• Language: English
• Published: 12-10-2021
• ISSN: 2078-256X
• DOI: 10.52727/2078-256X-2021-3-97-105

In a pandemic, a special group is made up of patients with cardiovascular pathology. Cardiovascular diseases are largely associated with an increase in mortality and an increased risk of complications in patients infected with the SARS-CoV-2 virus. This determines the importance of risk stratification, the choice of optimal personalized therapy and the study of the long-term prognosis of myocardial infarction against the background of infection caused by SARS-CoV-2. Despite the rapidly growing attention to this issue, the mechanisms of the relationship between cardiovascular disease and COVID-19 are not completely clear. We conducted a systematic review to summarize important aspects of COVID-19 for cardiologists. The authors discuss both well-studied factors of the infectious process leading to acute myocardial damage and decompensation of existing chronic cardiac diseases, and new, fundamental, determining prognosis and treatment. Information on the topic was used from publications based on the PubMed, Google Scholar and eLibrary.ru databases. This work was carried out within the framework of a research grant № 67573613 of Pfizer.